🥶 Corticosteroid Injection for Frozen Shoulder Simulator

Early Freezing Phase

Synovial lining inflames, shoulder stiffens, pain climbs steadily.

• 2–9 mo: Freezing phase duration (typical range)
• ↓ up to 70%: Capsule volume loss (vs healthy joint)
• 2–5%: Prevalence in adults (general population)
• 40–60: Peak age range (years old)

What triggers the freeze

Synovium thickens and inflames for unclear reasons.

Diabetics face triple the risk of frozen shoulder.

Pain before stiffness

Pain often precedes the loss of motion.

Why early treatment matters

Calming inflammation early may shorten the freeze.

Injection Administered

A needle delivers corticosteroid straight into the joint capsule.

• 40 mg: Typical dose (triamcinolone equiv.)
• <5 min: Procedure time (in-clinic injection)
• Ultrasound: Guidance method (improves accuracy)
• 22–25G: Needle gauge (posterior approach)

Reaching the joint space

Imaging guidance confirms placement inside the capsule.

Local versus systemic dosing

Intra-articular delivery concentrates the drug on-site.

Ultrasound guidance raises accurate placement above 90%.

Often paired with anesthetic

Lidocaine mixed in gives fast, short-lived pain relief.

Anti-Inflammatory Action

Steroid molecules shut down cytokine signaling in the synovium.

• IL-1, IL-6, TNF-α: Cytokines suppressed (key mediators)
• 24–72 h: Onset of action (molecular effect)
• Genomic: Mechanism class (gene transcription block)
• Glucocorticoid R: Receptor target (cytoplasmic receptor)

Genomic suppression pathway

Steroid-receptor complexes block inflammatory gene transcription.

One receptor complex can silence many cytokine genes.

Cellular calming

Fewer immune cells infiltrate the synovial lining.

Vascular effect

Reduced capillary leakiness lowers joint swelling.

Pain Reduction

Falling inflammation translates into measurable pain relief.

• ~50%: Pain drop by week 4 (average reported)
• +20–30%: ROM gain by week 6 (external rotation)
• ~70–80%: Responders (early-stage patients)
• Weeks 2–6: Best window (peak improvement)

A short lag before relief

Molecular effects take days to become noticeable.

Motion follows pain

Less pain lets patients move and stretch more.

Injection plus physical therapy outperforms either alone.

A plateau eventually appears

Improvement curves flatten after several weeks.

Limited Duration Effect

Relief is substantial but capsular fibrosis remains largely untouched.

• 6–12 wk: Relief duration (typical benefit window)
• ≤3 / yr: Repeat injections (to limit tissue harm)
• Minimal: Fibrosis reversal (steroid alone)
• ~30–35%: Late-stage ROM cap (if capsule thickened)

Inflammation is not fibrosis

Steroid quiets swelling, not scarred collagen.

Thickened capsule tissue needs stretching or release, not steroid.

Why late-stage responds less

Fibrotic capsules limit how far motion can improve.

What comes after

Physical therapy or capsule release often follows.